The Evolution of Therapies Targeting Bruton Tyrosine Kinase for the Treatment of Chronic Lymphocytic Leukaemia: Future Perspectives

SIMPLE SUMMARY: The development of drugs that successfully target Bruton tyrosine kinase (BTK) represents a major scientific and clinical advance for the treatment of chronic lymphocytic leukaemia (CLL). This article will begin by reviewing the scientific observations that underpinned the targeting...

Descripción completa

Detalles Bibliográficos
Autores principales: Eyre, Toby A., Riches, John C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177608/
https://www.ncbi.nlm.nih.gov/pubmed/37174062
http://dx.doi.org/10.3390/cancers15092596

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177608/
https://www.ncbi.nlm.nih.gov/pubmed/37174062
http://dx.doi.org/10.3390/cancers15092596

Ejemplares similares